Helen Leask, PhD

Cancer clinical trials: Can industry stack the deck?

Publish date: March 10, 2023

Experts: New research into age disparities in cancer drug trials finds participants “markedly younger” than intended patient populations.

Publish date: January 24, 2023

This often-missed myeloid neoplasm could be deadly and deserves greater attention, experts say.

Publish date: January 19, 2023

Older patients, even those with early disease, had much poorer survival after they were diagnosed with cervical cancer than their younger...

Publish date: November 15, 2022

In the wake of the FDA’s accelerated approval of teclistamab, myeloma specialists interpret the pros and cons.

Publish date: September 22, 2022

A photojournalist-turned-physician practiced in India and the United Kingdom before rising to prominence in U.S. community oncology.

Publish date: April 15, 2022

New data suggest that physicians should refer Hodgkin lymphoma patients for allogeneic HCT without delay when PD-1 treatments fail.

Publish date: April 14, 2022

In 1992, a young New Yorker was among the first Hodgkin lymphoma patients to undergo a successful bone marrow transplant. Three decades later,...

Publish date: January 21, 2022

MSKCC medical oncologists share expertise in HSCT, Spanish background, a gift for mentoring, and 100 peer-reviewed publications written together...